You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letters
Hyponatraemia during terlipressin therapy
  1. Aleksander Krag1,2,
  2. Lise Hobolth1,2,
  3. Søren Møller2,
  4. Flemming Bendtsen1
  1. 1Department of Gastroenterology, Hvidovre University Hospital, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
  2. 2Department of Clinical Physiology, Hvidovre University Hospital, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
  1. Correspondence to Dr Aleksander Krag, Department of Medical Gastroenterology 439, Hvidovre Hospital, Hvidovre DK-2650, Denmark; aleksanderkrag{at}hotmail.com

https://doi.org/10.1136/gut.2009.198382

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We have read with interest the study by Lo et al1 in a recent issue of Gut. Apart from the findings that short-term therapy with terlipressin in combination with ligation seems to improve outcome in bleeding oesophageal varices (BOVs) compared to longer treatment with terlipressin, a shorter treatment period with terlipressin most likely reduces the risk of severe side effects. Recently, a study observed that during a 5-day terlipressin treatment with 1 mg/4 h, the serum sodium decreased from 138±5 to 130±9 and in …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; not externally peer reviewed.